How big is the scaffold technology market?

The global scaffold technology market size was estimated at USD 1.76 billion in 2022 and is expected to reach USD 1.98 billion in 2023.

What is the scaffold technology market growth?

The global scaffold technology market is expected to grow at a compound annual growth rate of 13.87% from 2023 to 2030 to reach USD 4.92 billion by 2030.

Which segment accounted for the largest scaffold technology market share?

The hydrogel segment dominated the scaffold technology market with a share of 41.69% in 2022. This is attributable to the properties associated with the use of hydrogels such as the ease of loading cells and drugs for controlled drug delivery.

Who are the key players in the scaffold technology market?

Some key players operating in the scaffold technology market include Thermo Fisher Scientific, Inc.; Merck KGaA; Tecan Trading AG; REPROCELL Inc.; 3D Biotek LLC; Becton, Dickinson and Company; Medtronic; Xanofi; Molecular Matrix, Inc.; Matricel GmbH; Pelobiotech; 4titude, Corning Incorporated; Akron Biotech; Avacta Life Sciences Limited.; Vericel Corporation; NuVasive, Inc.; Allergan

What are the factors driving the scaffold technology market?

Key factors that are driving the scaffold technology market growth include rising demand for 3D cellular models in translational research, increasing demand for body reconstruction procedures and tissue engineering, and technological advancement of scaffold technology.

Which application segment dominated the scaffold technology market?

The stem cell therapy, regenerative medicine, and tissue engineering segment dominated the market for scaffold technology and accounted for the largest revenue share of 66.45% in 2022.